India to Myanmar: Diclofenac Export Trade Route
India has recorded 411 verified shipments of Diclofenac exported to Myanmar, representing a combined trade value of $11.7M USD. This corridor is served by 84 active Indian exporters, with an average shipment value of $28.5K USD. The leading Indian exporter is LINCOLN PHARMACEUTICALS LTD, which accounts for 51% of total export value with 6 shipments worth $6.0M USD. On the buying side, UNIVERSAL CO. LTD. is the largest importer in Myanmar with $5.9M USD in purchases. The top 3 suppliers — LINCOLN PHARMACEUTICALS LTD, ARAVIS PHARMACEUTICALS, KHANDELWAL LABORATORIES PRIVATE LIMITED — together control 61% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Myanmar Diclofenac corridor is one of India's established pharmaceutical export routes, with 411 shipments documented worth a combined $11.7M USD. The route is dominated by LINCOLN PHARMACEUTICALS LTD, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's diclofenac manufacturing sector.
Across 84 active suppliers, the average shipment value stands at $28.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with diclofenac's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 19.7%, placing it at rank #6 among India's top diclofenac export destinations globally.
On the import side, key buyers of Indian diclofenac in Myanmar include UNIVERSAL CO. LTD., TO THE ORDER , M/S. K.T.Z. CO., LTD., and 102 others. UNIVERSAL CO. LTD. is the single largest importer with 4 shipments valued at $5.9M USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ1
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#6
- Annual growth+19.7%
- Demand growth+18.7%
- Regulatory ease86/100
Top 10 Indian Diclofenac Exporters to Myanmar
Showing top 10 of 84 Indian suppliers exporting Diclofenac to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LINCOLN PHARMACEUTICALS LTD Avg $997.0K per shipment | 6 | $6.0M | 51.1% |
| 2 | ARAVIS PHARMACEUTICALS Avg $48.5K per shipment | 13 | $630.0K | 5.4% |
| 3 | KHANDELWAL LABORATORIES PRIVATE LIMITED Avg $12.1K per shipment | 39 | $473.0K | 4.0% |
| 4 | KHANDELWAL LABORATORIES PRIVATE LIMITED Avg $14.6K per shipment | 23 | $335.2K | 2.9% |
| 5 | RHYDBURG PHARMACEUTICALS LIMITED Avg $14.6K per shipment | 22 | $321.5K | 2.7% |
| 6 | RHYDBURG PHARMACEUTICALS LTD Avg $29.0K per shipment | 11 | $318.6K | 2.7% |
| 7 | S K age Exports Avg $17.6K per shipment | 18 | $317.1K | 2.7% |
| 8 | TROIKAA PHARMACEUTICALS LIMITED Avg $70.9K per shipment | 4 | $283.4K | 2.4% |
| 9 | TROIKAA PHARMACEUTICALS LIMITED Avg $28.1K per shipment | 9 | $253.0K | 2.2% |
| 10 | AMN LIFE SCIENCE PRIVATE LIMITED Avg $18.5K per shipment | 11 | $203.2K | 1.7% |
This table shows the top 10 of 84 Indian companies exporting diclofenac to Myanmar, ranked by total trade value. The listed exporters are: LINCOLN PHARMACEUTICALS LTD, ARAVIS PHARMACEUTICALS, KHANDELWAL LABORATORIES PRIVATE LIMITED , KHANDELWAL LABORATORIES PRIVATE LIMITED, RHYDBURG PHARMACEUTICALS LIMITED, RHYDBURG PHARMACEUTICALS LTD, S K age Exports , TROIKAA PHARMACEUTICALS LIMITED , TROIKAA PHARMACEUTICALS LIMITED, AMN LIFE SCIENCE PRIVATE LIMITED. LINCOLN PHARMACEUTICALS LTD is the dominant supplier with 6 shipments worth $6.0M USD, giving it a 51% market share. The top 3 suppliers together account for 61% of the total trade value on this route.
Showing top 10 of 84 total Indian exporters on the India to Myanmar Diclofenac export route.
Top 10 Diclofenac Importers in Myanmar
Showing top 10 of 105 known buyers in Myanmar receiving Diclofenac shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian diclofenac in Myanmar include UNIVERSAL CO. LTD., TO THE ORDER , M/S. K.T.Z. CO., LTD., , NA, AORTA COMPANY LIMITED, among 105 total buyers. The largest importer is UNIVERSAL CO. LTD., accounting for $5.9M USD across 4 shipments — representing 51% of all diclofenac imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UNIVERSAL CO. LTD. | 4 | $5.9M | 50.7% |
| 2 | TO THE ORDER | 21 | $443.0K | 3.8% |
| 3 | M/S. K.T.Z. CO., LTD., | 33 | $399.5K | 3.4% |
| 4 | NA | 10 | $371.2K | 3.2% |
| 5 | AORTA COMPANY LIMITED | 17 | $315.9K | 2.7% |
| 6 | MONDAY FAMILY PTE LTD | 4 | $304.9K | 2.6% |
| 7 | MONDAY FAMILY PTE LTD., | 5 | $284.4K | 2.4% |
| 8 | HAN IDEAL TRADING LTD | 4 | $283.4K | 2.4% |
| 9 | TO THE ORDER OF | 17 | $273.3K | 2.3% |
| 10 | TO THE ORDER | 9 | $196.3K | 1.7% |
Showing top 10 of 105 Diclofenac importers in Myanmar on this route.
Top 10 Diclofenac Formulations Imported by Myanmar
Showing top 10 of 272 product formulations shipped on the India to Myanmar Diclofenac route, ranked by trade value
Myanmar imports a wide range of diclofenac formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Chlorzoxazone, Diclofenac Sodium & Parac — accounts for $5.0M USD across 2 shipments. There are 272 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Chlorzoxazone, Diclofenac Sodium & Parac | 2 | $5.0M | 43.1% |
| 2 | Diclofenac Diethylamine, Linseed Oil, Me | 2 | $892.6K | 7.6% |
| 3 | PANAGESIC INJECTION DICLOFENAC SODIUM BP 25 MG BENZYL ALCOHOL BP 4 V V WATERFOR INJECTION BP Q S 20X5X3 ML | 4 | $304.9K | 2.6% |
| 4 | PARAFORTAN INJ.)DICLOFENAC INJ. 25 MG/ML | 22 | $266.7K | 2.3% |
| 5 | DICLOFENAC DIETHYLAMINE,LINSEED OIL,METH | 7 | $223.6K | 1.9% |
| 6 | DYNAPAR QPS,DICLOFENAC DIETHYLAMINE AND | 2 | $183.3K | 1.6% |
| 7 | PARAFORTAN INJ.(DICLOFENAC SODIUM INJECTION 25MG/ML)(PACK:10X10X3ML)(PHARMACEUTICAL FORMULATIONS) | 10 | $167.1K | 1.4% |
| 8 | DYNAPAR QPS, DICLOFENAC DIETHYLAMINE & A | 2 | $139.8K | 1.2% |
| 9 | PARAFORTAN INJ.(DICLOFENAC SODIUM INJ. 2 | 11 | $132.8K | 1.1% |
| 10 | DICLOFENAC DIETHYLAMINE,LINSEED OIL,METH | 2 | $123.9K | 1.1% |
Showing top 10 of 272 Diclofenac formulations imported by Myanmar on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 104 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's diclofenac exports to Myanmar are driven primarily by a handful of large-scale manufacturers. LINCOLN PHARMACEUTICALS LTD with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 84 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LINCOLN PHARMACEUTICALS LTD, ARAVIS PHARMACEUTICALS, KHANDELWAL LABORATORIES PRIVATE LIMITED — together account for 61% of total trade value on this route. The average shipment value of $28.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as diclofenac diethylamine, linseed oil, me and panagesic injection diclofenac sodium bp 25 mg benzyl alcohol bp 4 v v waterfor injection bp q s 20x5x3 ml, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, UNIVERSAL CO. LTD. is the largest importer with 4 shipments worth $5.9M USD — representing 51% of all diclofenac imports from India on this route. A total of 105 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $11.7M
- Avg. Shipment
- $28.5K
- Suppliers
- 84
- Buyers
- 105
- Transit (Sea)
- ~28 days
- Annual Growth
- +19.7%
Related Analysis
Other Diclofenac Routes
Unlock the Full India to Myanmar Diclofenac Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 411 shipments on this route.
Frequently Asked Questions — India to Myanmar Diclofenac Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Diclofenac to Myanmar?
The leading Indian exporters of Diclofenac to Myanmar are LINCOLN PHARMACEUTICALS LTD, ARAVIS PHARMACEUTICALS, KHANDELWAL LABORATORIES PRIVATE LIMITED . LINCOLN PHARMACEUTICALS LTD holds the largest market share at approximately 51% of total trade value on this route.
Q What is the total value of Diclofenac exports from India to Myanmar?
India exports Diclofenac to Myanmar worth approximately $11.7M USD across 411 recorded shipments. The average value per shipment is $28.5K USD.
Q Which ports does India use to ship Diclofenac to Myanmar?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 104 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Myanmar for Diclofenac?
The average transit time for Diclofenac shipments from India to Myanmar is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Myanmar Diclofenac trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 19.7% with demand growth tracking at 18.7%. The route is ranked #6 among India's top Diclofenac export destinations globally.
Q How many suppliers are active on the India to Myanmar Diclofenac route?
There are currently 84 active Indian suppliers exporting Diclofenac to Myanmar. The market is moderately concentrated with LINCOLN PHARMACEUTICALS LTD accounting for 51% of total shipment value.
Q Who are the main importers of Diclofenac from India in Myanmar?
The leading importers of Indian Diclofenac in Myanmar include UNIVERSAL CO. LTD., TO THE ORDER , M/S. K.T.Z. CO., LTD., , NA, AORTA COMPANY LIMITED. UNIVERSAL CO. LTD. is the largest buyer with 4 shipments worth $5.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Diclofenac.
- 2.Supplier/Buyer Matching: 84 Indian exporters and 105 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 411 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
411 Verified Shipments
84 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists